Van Creveld, pioneer of hemophilia care and coagulation research in the Netherlands
Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism
Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism
Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism
In praise of long-term prospective data collection
The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99
Prevention of venous thromboembolism after major orthopedic surgery
Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists
Antiphospholipid antibodies
Should our approach to the anticardiolipin assay change 20 years after its discovery?
The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies
Pathogenic antibodies to coagulation factors. Part one
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia
Non-fatal major bleeding during treatment with vitamin K antagonists
Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study
Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists
Role of the γ-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin–heparin
A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers
Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretion
Rapid and efficient incorporation of tissue factor into liposomes
Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles
A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formation
Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications
Antithrombotic prophylaxis in women with thrombophilia and pregnancy complications
Screening for thrombophilia in children
Does heparin therapy improve pregnancy outcome in patients with thrombophilias?
Association between the acquired free protein S deficiency in HIV-infected patients with the lipid profile levels
Protein Z gene polymorphisms are associated with protein Z plasma levels
Tissue factor expression and P2Y12 gene polymorphism
Treatment of patients initially for acute deep vein thrombosis with a low-molecular-weight heparin at a fixed, body weight-independent dosage
Establishing a normal range for D-dimer levels through pregnancy to aid in the diagnosis of pulmonary embolism and deep vein thrombosis
Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism
Effect of age on the assessment of clinical probability of pulmonary embolism by prediction rules
Potassium homeostasis in patients receiving prophylactic dose enoxaparin therapy
Search for red blood cell cytoskeleton abnormalities in patients with venous thrombosis
Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients
Hyperhomocysteinemia and severity of peripheral vascular disease
Hyperchomocysteinemia and severity of peripheral vascular disease
More on
Aspirin and platelet function
Ilsley Ingram
TALKING ABOUT…
Announcements
Erratum